Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,76 HKD | 0,00% | -6,11% | -45,82% |
Omzet 2024 * | 1,28 mld. 10,03 mld. 1,19 mld. | Omzet 2025 * | 1,92 mld. 15,03 mld. 1,79 mld. | Marktkapitalisatie | 2,92 mld. 22,85 mld. 2,72 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -103 mln. -806 mln. -96,02 mln. | Nettowinst (verlies) 2025 * | 28 mln. 219 mln. 26,1 mln. | EV/omzet 2024 * | 1,81 x |
Nettoliquiditeiten 2024 * | 606 mln. 4,74 mld. 565 mln. | Nettoliquiditeiten 2025 * | 398 mln. 3,12 mld. 371 mln. | EV/omzet 2025 * | 1,31 x |
K/w-verhouding 2024 * |
-31,5
x | K/w-verhouding 2025 * |
63,8
x | Werknemers | 6.937 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,03% |
Recentste transcriptie over Genscript Biotech Corporation
1 week | -6,11% | ||
Lopende maand | -25,79% | ||
1 maand | -27,79% | ||
3 maanden | -34,87% | ||
6 maanden | -45,71% | ||
Lopend jaar | -45,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Weihui Shao
CEO | Chief Executive Officer | - | 01-01-23 |
Ye Wang
FOU | Founder | 55 | 01-01-02 |
Shiniu Wei
DFI | Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hong Xin Guo
BRD | Director/Board Member | 61 | 24-08-15 |
Li Zhu
BRD | Director/Board Member | 74 | 01-01-10 |
Yue Xin Pan
BRD | Director/Board Member | 65 | 24-08-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.61% | 4 M€ | -27,92% | ||
1.43% | 2 M€ | -18,13% | - | |
0.56% | 3 M€ | -2,93% | - | |
0.49% | 2 M€ | -.--% | ||
0.47% | 2 M€ | -14,14% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 10,76 | -0,74% | 11 113 130 |
24-04-24 | 10,84 | -1,28% | 21 590 030 |
23-04-24 | 10,98 | -0,36% | 16 104 970 |
22-04-24 | 11,02 | +5,56% | 17 671 950 |
19-04-24 | 10,44 | -8,90% | 30 405 970 |
uitgestelde koers Hong Kong S.E., 25 april 2024 om 10:09 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-45,82% | 2,94 mld. | |
+1,12% | 43,84 mld. | |
+6,77% | 41,68 mld. | |
+45,26% | 41,25 mld. | |
-11,96% | 27,04 mld. | |
+6,01% | 25,53 mld. | |
-24,92% | 18,18 mld. | |
-3,63% | 12,29 mld. | |
+27,16% | 12,29 mld. | |
+7,30% | 11,15 mld. |